Lower Limb Spasticity clinical trials

Explore recruiting lower limb spasticity clinical trials.

Recruiting lower limb spasticity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lower Limb Spasticity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity caused by stroke or traumatic brain injury in adult subjects, followed by an open label extension with or without combined upper limb treatment

France, Slovakia, Italy, Spain, Poland, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, open-label, non-randomized, single-arm, dose titration study to investigate the efficacy and safety of IncobotulinumtoxinA in children deemed to require a total body dose up to 22U/kg (maximum dose 550U) during the study period for the treatment of upper and lower limb spasticity due to cerebral palsy. PROTOCOL CODE: INCIPIT

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A prospective, randomized, double-blind, placebo-controlled, two-stage, multicenter study with an open-label extension period to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity in children and adolescents with cerebral palsy

Latvia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lower Limb Spasticity trials by city

Lower Limb Spasticity in Toronto Lower Limb Spasticity in Vancouver Lower Limb Spasticity in Montreal Lower Limb Spasticity in Calgary Lower Limb Spasticity in Edmonton Lower Limb Spasticity in Ottawa Lower Limb Spasticity in Winnipeg Lower Limb Spasticity in Quebec City Lower Limb Spasticity in Hamilton Lower Limb Spasticity in Kitchener Lower Limb Spasticity in London Lower Limb Spasticity in Halifax Lower Limb Spasticity in New York Lower Limb Spasticity in Los Angeles Lower Limb Spasticity in Chicago Lower Limb Spasticity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease